AKESO 09926Hong Kong Stock Exchange

109.1003.22%( +3.400 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
AKESO (09926) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2020-04-24
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG0146B1032
Southbound Connect
Shanghai · Shenzhen

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)3.61B32/112
Net Profit (Last FY)-1.31B119/125
ROE (Last FY)-12.30%67/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
XIA Yu Executive Director
LI Baiyong Executive Director
WANG Zhongmin Maxwell Executive Director
ZHANG Peng Executive Director
XIE Ronggang Non-Executive Director
ZENG Junwen Independent Non-Executive Director
XU Yan Independent Non-Executive Director
TAN Bo Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2024-07-01.

About this page

This page shows AKESO (09926) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.